CME plans to start trading futures contracts for Bitcoin Cash (BCH) and Uniswap (UNI) on October 19, adding to its existing lineup of single-asset crypto futures, which will total 11 assets. The BCH futures will have standard contracts covering 250 BCH and micro contracts covering 25 BCH, while UNI futures will have standard contracts for 10,000 UNI and micro contracts for 1,000 UNI. This launch is significant as a six-month trading history for UNI futures could meet SEC requirements for a spot Uniswap ETF listing, aiding Bitwise's pending ETF application. The new contracts provide regulated tools for investors to manage price risk as the crypto market matures, with both contracts currently pending regulatory review.
CME's plan to launch Bitcoin Cash (BCH) and Uniswap (UNI) futures is noted here with Pluang market data as of Oct 19, 2026 14:01 WIB. For readers following major cryptocurrencies, 36 of 50 priced assets rose today while 13 fell. Among selected tokens, UNI is priced at Rp132.881 with a 1-day change of +2.91% and Pluang order activity showing 86% Sell / 14% Buy, highlighting notable trading interest.
Jyske Bank has repurchased shares valued at approximately DKK 2.15 billion as part of its ongoing share buyback program running from February 2026 to January 2027. The bank has acquired a total of 2,235,959 treasury shares, representing 3.84% of its ...
Jyske Bank is conducting a share buyback program from February 5, 2026, to January 29, 2027, with a maximum value of DKK 3 billion. As of mid-October 2026, the bank has repurchased shares worth approximately DKK 2.15 billion at an average price of DK...
Oculis Holding AG has completed patient randomization in its PREDICT-1 clinical trial testing Licaminlimab, a precision medicine targeting TNFR1-mediated dry eye disease (DED). Two-thirds of the 176 enrolled patients carry a genetic variant linked to...
Ekalia, a joint venture between IBA and Framatome, has signed a collaboration agreement with Telix Pharmaceuticals to accelerate the production of astatine-211 in the United States. Astatine-211 is a promising alpha-emitting radioisotope used in targ...
At ESMO 2026, Roche presented key Phase III trial results showcasing significant advances in cancer treatment. Divarasib demonstrated superior efficacy over first-generation KRAS G12C inhibitors in advanced lung cancer, potentially setting a new stan...
